Mark Adamchak

CIK: 0002036536

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)4 (50.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

BNGO

Bionano Genomics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (8 total)

BNGO
Bionano Genomics, Inc.
Aug 3, 2026
Award(A)
Stock Option (Right to Buy)
Direct
5K shares-
BNGO
Bionano Genomics, Inc.
Jun 3, 2026
Tax Payment(F)
Direct
7 shares at avg. $1.30$9.1
BNGO
Bionano Genomics, Inc.
Feb 17, 2026
Tax Payment(F)
Direct
3 shares at avg. $1.10$3.3
BNGO
Bionano Genomics, Inc.
Feb 2, 2026
Award(A)
Stock Option (Right to Buy)
Direct
10.9K shares-
BNGO
Bionano Genomics, Inc.
Jun 3, 2025
Tax Payment(F)
Direct
7 shares at avg. $3.69$25.83
BNGO
Bionano Genomics, Inc.
Mar 14, 2025
Award(A)
Stock Option (Right to Buy)
Direct
3K shares-
BNGO
Bionano Genomics, Inc.
Feb 15, 2025
Tax Payment(F)
Direct
4 shares at avg. $5.73$22.92
BNGO
Bionano Genomics, Inc.
Oct 1, 2024
Award(A)
Stock Option (Right to Buy)
Direct
17.5K shares-

		Type	Shares	Price		Ownership
Aug 3, 2026	BNGO Bionano Genomics, Inc.	Award(A) Stock Option (Right to Buy)	5,000	-	-	Direct
Jun 3, 2026	BNGO Bionano Genomics, Inc.	Tax Payment(F)	7	$1.30	$9	Direct
Feb 17, 2026	BNGO Bionano Genomics, Inc.	Tax Payment(F)	3	$1.10	$3	Direct
Feb 2, 2026	BNGO Bionano Genomics, Inc.	Award(A) Stock Option (Right to Buy)	10,890	-	-	Direct
Jun 3, 2025	BNGO Bionano Genomics, Inc.	Tax Payment(F)	7	$3.69	$26	Direct
Mar 14, 2025	BNGO Bionano Genomics, Inc.	Award(A) Stock Option (Right to Buy)	3,029	-	-	Direct
Feb 15, 2025	BNGO Bionano Genomics, Inc.	Tax Payment(F)	4	$5.73	$23	Direct
Oct 1, 2024	BNGO Bionano Genomics, Inc.	Award(A) Stock Option (Right to Buy)	17,500	-	-	Direct

1-8 of 8 transactions

About Adamchak Mark

Adamchak Mark (SEC CIK 0002036536) files insider reports with the SEC as Principal Accounting Officer of Bionano Genomics, Inc. (BNGO).

Signal8 holds 10 ownership filings by Adamchak Mark (2 Form 3, 8 Form 4), filed between Sep 30, 2024 and Aug 5, 2026. Those filings report 8 transactions, from Oct 1, 2024 to Aug 3, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Adamchak Mark's filings is in SAN DIEGO, CA.

Recent filings by Adamchak Mark

Aug 3, 2026: Grant or award of BNGO derivative securities (Form 4, code A).
Jun 3, 2026: Tax withholding of BNGO shares (Form 4, code F).
Feb 17, 2026: Tax withholding of BNGO shares (Form 4, code F).
Feb 2, 2026: Grant or award of BNGO derivative securities (Form 4, code A).
Jun 3, 2025: Tax withholding of BNGO shares (Form 4, code F).

Other insiders filing for Bionano Genomics, Inc. (BNGO)

Luderer Albert, Interim Chief Executive
Dixon Jonathan V., General Counsel
OLDAKOWSKI MARK, Chief Operating Officer
Hastie Alex Reid, Chief Scientific Officer
Chaubey Alka, CHIEF MEDICAL OFFICER
Rajkovic Aleksandar, Director

How to read Form 4 transaction codes